Nedlands-based pharmaceutical company PharmAust Ltd will take a 39.5 per cent stake in Nasdaq-listed US-based Commonwealth Biotechnologies Inc in exchange for its discovery chemistry subsidiary, Mimotopes Pty Ltd.
Nedlands-based pharmaceutical company PharmAust Ltd will take a 39.5 per cent stake in NASDAQ-listed US-based Commonwealth Biotechnologies Inc in exchange for its its discovery chemistry subsidiary Mimotopes Pty Ltd.
